Found: 50
Select item for more details and to access through your institution.
Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203).
- Published in:
- 2018
- By:
- Publication type:
- journal article
MODUL—a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 6, p. 1197, doi. 10.1007/s00432-018-2632-6
- By:
- Publication type:
- Article
Response.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 20, p. 1602, doi. 10.1093/jnci/84.20.1602
- By:
- Publication type:
- Article
BOOK REVIEWS.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 17, p. 1358
- By:
- Publication type:
- Article
Phase I Trial Of Fluorouracil Modulation by N-Phosphonacety-L-aspartate and 6-Methylmercaptopurine Riboside: Optimization of 6-Methylmercaptopurine Riboside Dose and Schedule Through Biochemical Analysis of Sequential Tumor Biopsy Specimens.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 17, p. 1235, doi. 10.1093/jnci/83.17.1235
- By:
- Publication type:
- Article
Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00201
- By:
- Publication type:
- Article
Pharmacologic Study of Etoposide and Cisplatin by the Intraperitoneal Route.
- Published in:
- 1991
- By:
- Publication type:
- Other
2-Deoxycoformycin (Pentostatin) for Lymphoid Malignancies.
- Published in:
- Annals of Internal Medicine, 1988, v. 108, n. 5, p. 733, doi. 10.7326/0003-4819-108-5-733
- By:
- Publication type:
- Article
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 2, p. 1099, doi. 10.1245/s10434-022-12705-8
- By:
- Publication type:
- Article
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 6, p. 1306, doi. 10.1007/s10637-022-01311-w
- By:
- Publication type:
- Article
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01367-8
- By:
- Publication type:
- Article
Strong Signature of Natural Selection within an FHIT Intron Implicated in Prostate Cancer Risk.
- Published in:
- PLoS ONE, 2008, v. 3, n. 10, p. 1, doi. 10.1371/journal.pone.0003533
- By:
- Publication type:
- Article
High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experience.
- Published in:
- 2002
- By:
- Publication type:
- journal article
DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 4017, doi. 10.3390/cancers14164017
- By:
- Publication type:
- Article
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11539-1
- By:
- Publication type:
- Article
Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials.
- Published in:
- Tomography: A Journal for Imaging Research, 2023, v. 9, n. 2, p. 657, doi. 10.3390/tomography9020053
- By:
- Publication type:
- Article
Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 8, p. 1985
- By:
- Publication type:
- Article
A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients.
- Published in:
- Nature Communications, 2015, v. 6, n. 7, p. 7686, doi. 10.1038/ncomms8686
- By:
- Publication type:
- Article
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 97, doi. 10.1007/s00280-009-1008-7
- By:
- Publication type:
- Article
Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 497, doi. 10.1007/s00280-004-0938-3
- By:
- Publication type:
- Article
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 5, p. 404, doi. 10.1007/s00280-003-0754-1
- By:
- Publication type:
- Article
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 357, doi. 10.1007/s00280-003-0735-4
- By:
- Publication type:
- Article
Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 3, p. 217, doi. 10.1007/s00280-003-0640-x
- By:
- Publication type:
- Article
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 309, doi. 10.1038/s41416-023-02276-0
- By:
- Publication type:
- Article
Early treatment-related neutropenia predicts response to palbociclib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 9, p. 1159, doi. 10.1002/jcph.902
- By:
- Publication type:
- Article
The Next Generation of Targeted Therapy Trials in Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2014, v. 12, n. 12, p. 852
- By:
- Publication type:
- Article
Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 125, doi. 10.1007/s11523-022-00875-0
- By:
- Publication type:
- Article
A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors.
- Published in:
- Targeted Oncology, 2019, v. 14, n. 5, p. 613, doi. 10.1007/s11523-019-00661-5
- By:
- Publication type:
- Article
A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 9, p. 1463, doi. 10.1002/cncr.29213
- By:
- Publication type:
- Article
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 1, p. 77, doi. 10.1002/cncr.28294
- By:
- Publication type:
- Article
Do Phase 1 Patients Have Greater Needs for Palliative Care Compared With Other Cancer Patients?
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 2, p. 446, doi. 10.1002/cncr.24025
- By:
- Publication type:
- Article
Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1864, doi. 10.1634/theoncologist.2020-0681
- By:
- Publication type:
- Article
Robert L. Comis: In Memoriam.
- Published in:
- 2017
- By:
- Publication type:
- Obituary
Phase I/II Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 952, doi. 10.1634/theoncologist.2015-0108
- By:
- Publication type:
- Article
The Present and Future of Angiogenesis-Directed Treatments of Colorectal Cancer.
- Published in:
- Oncologist, 2006, v. 11, n. 9, p. 992, doi. 10.1634/theoncologist.11-9-992
- By:
- Publication type:
- Article
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 23, p. 5022, doi. 10.1002/cncr.33209
- By:
- Publication type:
- Article
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1487, doi. 10.1093/jnci/djae114
- By:
- Publication type:
- Article
Modified Eligibility Criteria: Patient Access and Subpopulation Applicability vs Efficiency in Drug Development.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 11, p. 1429, doi. 10.1093/jnci/djac155
- By:
- Publication type:
- Article
Current Activities of the Coalition of Cancer Cooperative Groups.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab -Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01256
- By:
- Publication type:
- Article